Tenaya Therapeutics (TNYA) said late Monday it priced an underwritten public offering of 75 million units at $0.70 per unit for gross proceeds of $52.5 million.
Each unit consists of one common share, one warrant to purchase one common share at an exercise price of $0.80 per share, and one warrant to purchase one-half of a common share at an exercise price of $0.70 per share.
Net proceeds will be used to fund clinical development activities, working capital and general corporate purposes, the company said.
Closing of the offering is expected on or about Wednesday, subject to customary conditions.
Tenaya Therapeutics shares fell more than 27% in after-hours activity Monday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。